Calcimimetics Adherence and Preference in the Management of Uremic Secondary Hyperparathyroidism (SHPT) in Europe

被引：0

作者：

Nduka, Chidozie U. ^{[1
]}

Louie, Karly S. ^{[1
]}

Taylor, Jo ^{[2
]}

Hall, Matt ^{[3
]}

Aucella, Filippo ^{[4
]}

Torres, Pablo A. Urena ^{[5
,6
]}

Labriola, Laura ^{[7
]}

Evenepoel, Pieter ^{[8
]}

Ma, Junjie ^{[12
]}

Saleem, Najma ^{[12
]}

Pisoni, Ronald L. ^{[9
]}

Fouqueray, Bruno L. ^{[10
]}

Horne, Robert ^{[11
]}

机构：

[1] Amgen Inc, Uxbridge, Middx, England

[2] Dorset Cty Hosp NHS Fdn Trust, Dorchester, England

[3] Nottingham Univ Hosp NHS Trust, Nottingham, England

[4] Fdn IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy

[5] AURA Paris Nord, St Ouen, France

[6] Univ Paris 05, Necker Hosp, Paris, France

[7] Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, Brussels, Belgium

[8] Univ Hosp Leuven, Div Nephrol, Dept Immunol & Microbiol, Leuven, Belgium

[9] Arbor Res Collaborat Hlth, Ann Arbor, MI USA

[10] Amgen GmbH, Rotkreuz, Switzerland

[11] UCL, Sch Pharm, London, England

[12] Amgen Inc, Thousand Oaks, CA USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

SA-PO325

引用

页码：694 / 694

页数：1

共 50 条

[21] New therapies for uremic secondary hyperparathyroidism
Torres, PU
Prié, D
Beck, L
Friedlander, G
JOURNAL OF RENAL NUTRITION, 2006, 16 (02) : 87 - 99
[22] The calcimimetic AMG 073: A potential novel therapy for secondary hyperparathyroidism (SHPT).
Block, GA
Coyne, DW
Goodman, WG
Silver, MR
Blaisdell, PW
Olson, KA
Turner, SA
Lindberg, JS
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 572A - 572A
[23] The Use of Calcimimetics for the Treatment of Secondary Hyperparathyroidism: A 10 Year Evidence Review
Rodriguez, Mariano
Goodman, William G.
Liakopoulos, Vassilios
Messa, Piergiorgio
Wiecek, Andrzej
Cunningham, John
SEMINARS IN DIALYSIS, 2015, 28 (05) : 497 - 507
[24] Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis DISCUSSION
Weber, Collin J.
Brunaud, Laurent
Wilhelm, Scott
Holt, Shelby A.
SURGERY, 2016, 159 (01) : 191 - 192
[25] Therapy of secondary hyperparathyroidism to date: vitamin D analogs, calcimimetics or both?
Cannella, Giuseppe
Messa, Piergiorgio
JOURNAL OF NEPHROLOGY, 2006, 19 (04) : 399 - 402
[26] Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs
Brancaccio, Diego
Cozzolino, Mario
Galassi, Andrea
Chiarelli, Giusy
Butti, Alessandra
Bellasi, Antonio
Rocca-Rey, Lisa
Volpi, Angela
Anelli, Adriana
Zoni, Ulisse
Fusaro, Maria
Brambilla, Claudia
Missaglia, Elena
Crovetto, Cesar
Russo, Micol
Longhini, Carlo
Provenzano, Rossana
Incalcaterra, Francesca
Cerasola, Giovanni
Vecchi, Maurizio Li
Gallieni, Maurizio
JOURNAL OF NEPHROLOGY, 2007, 20 (01) : 3 - 9
[27] CINACALCET FOR NORMO- AND HYPERCALCEMIC SECONDARY HYPERPARATHYROIDISM (SHPT) AFTER RENAL TRANSPLANT
Vicente Torregrosa, Jose
Morales, Enrique
Manuel Diaz, Juan
Crespo, Josep
Bravo, Juan
Gomez, Gonzalo
Angel Gentil, Miguel
Rodriguez-Benot, Alberto
Rodriguez, Minerva
Lopez, Veronica
Gutierrez, Alex
Jimeno, Luisa
Jose Perez-Saez, Maria
Romero, Rafael
Gomez, Carlos
TRANSPLANT INTERNATIONAL, 2013, 26 : 242 - 242
[28] AN OVERVIEW OF NURSES' MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM: HOW IS EUROPE DOING?
de Barbieri, Ilaria
Baumann, Jacqueline
Casal, Maria Cruz
Gurevich, Andrey
Pancirova, Jitka
Poulia, Kalliopi-Anna
Riemann, Aase
JOURNAL OF RENAL CARE, 2015, 41 (03) : 202 - 210
[29] UREMIC THROMBOCYTOPATHY - THE ROLE OF SECONDARY HYPERPARATHYROIDISM (HPT)
DOCCI, D
TURCI, F
BALDRATI, L
DELVECCHIO, C
PISTOCCHI, E
KIDNEY INTERNATIONAL, 1985, 28 (02) : 241 - 241
[30] HETEROGENIETY OF SECONDARY HYPERPARATHYROIDISM IN UREMIC PATIENTS ON DIALYSIS
COBURN, JW
DIDOMENICO, NC
BRYCE, GF
CHANG, PC
MILLER, ON
CLINICAL RESEARCH, 1982, 30 (02): : A539 - A539

← 1 2 3 4 5 →